tiprankstipranks
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market
MDP
Medexus Pharmaceuticals Inc
RESEARCH TOOLSreports
Want to see TSE:MDP full AI Analyst Report?

Medexus Pharmaceuticals Inc (MDP) Ratios

67 Followers

Medexus Pharmaceuticals Inc Ratios

TSE:MDP's free cash flow for Q3 2026 was C$0.54. For the 2026 fiscal year, TSE:MDP's free cash flow was decreased by C$ and operating cash flow was C$0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
 1.12 1.09 0.65 0.82 1.47
Quick Ratio
 0.62 0.63 0.44 0.46 1.10
Cash Ratio
 0.24 0.08 0.16 0.21 0.59
Solvency Ratio
 0.09 0.04 0.05 0.03 -0.16
Operating Cash Flow Ratio
 0.28 0.28 -0.01 -0.02 0.13
Short-Term Operating Cash Flow Coverage
 2.41 1.19 -0.03 -0.06 0.38
Net Current Asset Value
C$ -32.80MC$ -52.91MC$ -114.73MC$ -102.71MC$ -71.92M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.32 0.59 0.39 0.38
Debt-to-Equity Ratio
 0.49 1.65 4.22 3.08 3.13
Debt-to-Capital Ratio
 0.33 0.62 0.81 0.76 0.76
Long-Term Debt-to-Capital Ratio
 0.26 0.53 0.54 0.69 0.65
Financial Leverage Ratio
 2.97 5.14 7.19 7.83 8.24
Debt Service Coverage Ratio
 1.19 0.65 0.31 0.52 -0.87
Interest Coverage Ratio
 0.47 0.81 0.56 -1.23 -0.14
Debt to Market Cap
 0.27 1.38 2.64 0.95 0.39
Interest Debt Per Share
 0.96 2.83 5.42 3.45 4.38
Net Debt to EBITDA
 0.66 2.32 4.77 2.79 -1.39
Profitability Margins
Gross Profit Margin
53.87%52.64%55.54%49.45%52.73%
EBIT Margin
6.08%11.91%7.92%10.96%-39.56%
EBITDA Margin
15.89%17.05%14.93%19.77%-29.63%
Operating Profit Margin
2.77%9.55%7.04%-19.55%-1.73%
Pretax Profit Margin
-0.03%0.09%-4.66%-4.98%-39.54%
Net Profit Margin
-0.27%-0.19%1.13%-3.75%-35.48%
Continuous Operations Profit Margin
-0.27%-0.19%1.13%-3.75%-35.48%
Net Income Per EBT
1088.00%-201.89%-24.22%75.37%89.72%
EBT Per EBIT
-0.91%0.98%-66.21%25.47%2289.32%
Return on Assets (ROA)
-0.18%-0.14%0.76%-2.07%-19.03%
Return on Equity (ROE)
-0.52%-0.71%5.44%-16.18%-156.87%
Return on Capital Employed (ROCE)
2.98%12.06%15.70%-18.96%-1.27%
Return on Invested Capital (ROIC)
2.76%-20.71%-1.74%-11.55%-1.01%
Return on Tangible Assets
-0.34%-0.26%1.51%-5.54%-45.96%
Earnings Yield
-0.29%-0.60%3.82%-4.71%-23.54%
Efficiency Ratios
Receivables Turnover
 8.40 4.70 3.64 5.32 3.37
Payables Turnover
 1.06 6.91 4.73 2.57 2.53
Inventory Turnover
 1.47 1.74 2.10 1.82 2.57
Fixed Asset Turnover
 217.58 145.31 120.24 62.82 100.20
Asset Turnover
 0.64 0.73 0.67 0.55 0.54
Working Capital Turnover Ratio
 -40.22 -6.73 -4.25 20.18 6.50
Cash Conversion Cycle
 -52.74 234.53 196.65 127.78 106.61
Days of Sales Outstanding
 43.43 77.58 100.27 68.56 108.43
Days of Inventory Outstanding
 249.07 209.78 173.53 200.99 142.17
Days of Payables Outstanding
 345.25 52.83 77.15 141.77 143.99
Operating Cycle
 292.50 287.36 273.80 269.55 250.60
Cash Flow Ratios
Operating Cash Flow Per Share
 0.54 0.84 -0.07 -0.06 0.33
Free Cash Flow Per Share
 0.53 0.83 -0.09 -0.46 -0.38
CapEx Per Share
 <0.01 0.01 0.02 0.40 0.71
Free Cash Flow to Operating Cash Flow
 0.99 0.99 1.25 7.54 -1.13
Dividend Paid and CapEx Coverage Ratio
 85.11 70.35 -3.99 -0.15 0.47
Capital Expenditure Coverage Ratio
 85.11 70.35 -3.99 -0.15 0.47
Operating Cash Flow Coverage Ratio
 0.68 0.38 -0.02 -0.02 0.09
Operating Cash Flow to Sales Ratio
 0.17 0.17 -0.01 -0.02 0.06
Free Cash Flow Yield
18.36%51.33%-5.65%-14.56%-4.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -352.00 -167.93 26.18 -21.22 -4.25
Price-to-Sales (P/S) Ratio
 0.96 0.32 0.30 0.80 1.51
Price-to-Book (P/B) Ratio
 1.83 1.19 1.42 3.43 6.66
Price-to-Free Cash Flow (P/FCF) Ratio
 5.56 1.95 -17.70 -6.87 -21.00
Price-to-Operating Cash Flow Ratio
 5.51 1.92 -22.13 -51.77 23.83
Price-to-Earnings Growth (PEG) Ratio
 3.33 1.50 -0.18 0.23 >-0.01
Price-to-Fair Value
 1.83 1.19 1.42 3.43 6.66
Enterprise Value Multiple
 6.69 4.18 6.76 6.82 -6.48
Enterprise Value
 103.86M 80.58M 109.02M 103.42M 152.95M
EV to EBITDA
 6.57 4.18 6.76 6.82 -6.48
EV to Sales
 1.04 0.71 1.01 1.35 1.92
EV to Free Cash Flow
 6.05 4.37 -60.36 -11.63 -26.75
EV to Operating Cash Flow
 5.98 4.31 -75.50 -87.65 30.36
Tangible Book Value Per Share
 -0.70 -1.98 -5.36 -5.13 -4.54
Shareholders’ Equity Per Share
 1.61 1.36 1.12 0.91 1.19
Tax and Other Ratios
Effective Tax Rate
 -9.88 3.02 1.24 0.25 0.10
Revenue Per Share
 3.07 5.06 5.41 3.94 5.24
Net Income Per Share
 >-0.01 >-0.01 0.06 -0.15 -1.86
Tax Burden
 14.99 -2.02 -0.24 0.75 0.90
Interest Burden
 >-0.01 <0.01 -0.59 -0.45 1.00
Research & Development to Revenue
 0.09 0.07 0.03 0.10 0.06
SG&A to Revenue
 0.40 0.25 0.34 0.38 0.24
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.01 0.02 0.02
Income Quality
 -63.83 -87.45 -1.18 0.41 -0.18
Currency in CAD